Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
09/29/2023 144 Form 144 - Report of proposed sale of securities:
08/18/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 D Form D - Notice of Exempt Offering of Securities:
08/16/2023 144 Form 144 - Report of proposed sale of securities:
08/04/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
Docs: "PacBio Announces Second Quarter 2023 Financial Results",
"PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer PacBio will combine Apton’s proprietary sequencing technology with its highly accurate Sequencing by Binding chemistry to develop a high-throughput sequencer designed to deliver billions of reads per flow cell",
"PacBio Begins Commercialization of the Onso Short-Read Sequencing System The Onso platform delivers extraordinary accuracy which creates new possibilities for research and translational sequencing applications"
06/30/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Indenture, by and between Pacific Biosciences of California, Inc. and U.S. Bank Trust Company, National Association, as Trustee"
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/23/2023 SD Form SD - Specialized disclosure report:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/13/2023 ARS Form ARS - Annual Report to Security Holders:
04/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/27/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A ARK Investment Management LLC reports a 11.4% stake in Pacific Biosciences of California, Inc.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 SC 13G/A Sumitomo Mitsui Trust Holdings, Inc. reports a 6.3% stake in Pacific Biosciences of California, Inc.
01/27/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement",
"Re: Registration Statement on Form S-3",
"Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock"
01/25/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
01/24/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock",
"Disclosure Update as of January 24, 2023",
"Letter Relating to Employment Terms by and between the Registrant and Jeff Eidel effective August 16, 2022",
"Change in Control and Severance Agreement by and between the Registrant and Susan G. Kim effective February 3, 2021"
01/09/2023 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Exhibit 99.1 PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022"
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/07/2022 8-K Quarterly results
Docs: "THIRD AMENDED AND RESTATED BYLAWS OF PACIFIC BIOSCIENCES OF CALIFORNIA, INC.",
"PacBio Announces Third Quarter 2022 Financial Results"
10/25/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
08/05/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/03/2022 8-K Quarterly results
Docs: "PacBio Announces Second Quarter 2022 Financial Results"
06/30/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy